# Monitoring the IgG/IgM Antibodies in COVID-19 Patients

> **NCT04810117** · — · COMPLETED · sponsor: **University of Sargodha** · enrollment: 373 (actual)

## Conditions studied

- COVID-19 Infections

## Interventions

- **DIAGNOSTIC_TEST:** Serodiagnosis of IgG and IgM

## Key facts

- **NCT ID:** NCT04810117
- **Lead sponsor:** University of Sargodha
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-15
- **Primary completion:** 2021-11-30
- **Final completion:** 2022-04-30
- **Target enrollment:** 373 (ACTUAL)
- **Last updated:** 2022-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04810117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04810117, "Monitoring the IgG/IgM Antibodies in COVID-19 Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04810117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*